San Diego, CA -- (SBWire) -- 06/03/2022 --An investorsin shares of Ardelyx, Inc. (NASDAQ: ARDX) filed a lawsuit against certain directors of Ardelyx, Inc over alleged breaches of fiduciary duties.
Investors who are current long term investors in Ardelyx, Inc. (NASDAQ: ARDX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges that certain directors engaged in insider trading and made false and misleading statements about Ardelyx's lead product candidate, tenapanor that lead to a 74% stock drop after regulators found issues with certain data about the drug.
The lawsuit against certain directors over alleged breaches of fiduciary duties follows a lawsuit that was filed against Ardelyx over alleged Securities Laws Violations. According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that Ardelyx and the other named defendants made materially false and misleading statements regarding tenapanor and the likelihood that it would be approved by the FDA, which led investors to suffer significant losses.
Those who purchased shares of Ardelyx, Inc. (NASDAQ: ARDX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Ardelyx, Inc. (NASDAQ:ARDX) Long Term Investor Alert: Lawsuit Filed Against Directors
A lawsuit was filed by a current investors in Ardelyx, Inc. (NASDAQ:ARDX) shares over alleged breaches of fiduciary duty by certain directors and NASDAQ:ARDX stockholders should contact the Shareholders Foundation.